Want to track PRQR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ProQR Therapeutics N.V. (PRQR) Statistics
Valuation metrics
Market Cap 165.34M
Enterprise value 49.32M
Trailing P/E (ttm) -3.68
Forward P/E -3.69
PEG ratio -0.63
Price/Sales (ttm) 8.25
Price/Book (mrq) 2.01
Enterprise Value/Revenue 2.66
Enterprise Value/EBITDA -1.31
Overview
Shares outstanding 105.36M
Float 64.35M
Shares short 1.67M
% Held by insiders 0.18%
% Held by institutions 0.51%
Average volume (10 days) 677.1K
Average volume (90 days) 629.47K
Price summary
52-Week low 1.3
52-Week high 3.1
Beta 0.09
50-Day moving average 1.84
200-Day moving average 1.67
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -2.28%
Operating margin -2.33%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.68%
Income Statement
Revenue (ttm) 19.27M
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) 0.06%
Gross profit (ttm) 19.27M
EBITDA -50.14M
Net income to common (ttm) -49.72M
Diluted EPS (ttm) -0.39
Quarterly earnings growth (yoy) 0.09%
Balance Sheet
Total cash (mrq) 108.91M
Total cash per share (mrq) 1.06
Total debt (mrq) 18.81M
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 3.49%
Book value per share (mrq) 0.72
Cash Flow
Cash flow statement -62.22M
Levered free cash flow (LFCF) -37.76M
2026 © Marketlog. All Rights Reserved.
